Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Amortization - GoodwillCost of RevenueEBIATGross ProfitReceivables - NetRent ExpenseWages, Salaries and Other
Ratios

Avricore Health (AVCRF) Shares Outstanding (2017 - 2024)

Avricore Health has reported Shares Outstanding over the past 8 years, most recently at $72.5 million for Q4 2024.

  • Quarterly Shares Outstanding fell 0.94% to $72.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $72.5 million through Dec 2024, down 0.94% year-over-year, with the annual reading at $74.0 million for FY2024, 0.17% changed from the prior year.
  • Shares Outstanding was $72.5 million for Q4 2024 at Avricore Health, down from $73.2 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $77.4 million in Q4 2021 and troughed at $7670.5 in Q4 2020.
  • The 5-year median for Shares Outstanding is $73.1 million (2022), against an average of $59.2 million.
  • Year-over-year, Shares Outstanding tumbled 46.23% in 2020 and then soared 16997.81% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $452562.3 in 2020, then soared by 16997.81% to $77.4 million in 2021, then fell by 5.51% to $73.1 million in 2022, then grew by 0.11% to $73.2 million in 2023, then fell by 0.94% to $72.5 million in 2024.
  • Per Business Quant, the three most recent readings for AVCRF's Shares Outstanding are $72.5 million (Q4 2024), $73.2 million (Q4 2023), and $73.1 million (Q4 2022).